These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8666016)

  • 1. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
    Hatta K; Wolterink G; Van Ree JM
    Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin-(10-16) antagonizes behavioral responses elicited by melatonin following injection into the nucleus accumbens of rats.
    Gaffori O; van Ree JM
    Life Sci; 1985 Jul; 37(4):357-64. PubMed ID: 3159948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropeptides and social behavior of rats tested in dyadic encounters.
    Niesink RJ; van Ree JM
    Neuropeptides; 1984 Nov; 4(6):483-96. PubMed ID: 6151143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.
    Gaffori O; Van Ree JM
    Neuropharmacology; 1985 Mar; 24(3):237-44. PubMed ID: 2859542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
    Pinnock RD; Woodruff GN; Turnbull MJ
    Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of non-opioid fragments of beta-endorphin.
    van Ree JM; de Wied D
    Prog Clin Biol Res; 1985; 192():277-84. PubMed ID: 2934744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of central and peripheral injection of various analogues and metabolites of thyrotropin releasing hormone (TRH).
    Heal DJ; Sabbagh A; Youdim MB; Green AR
    Neuropharmacology; 1981 Oct; 20(10):947-57. PubMed ID: 6795523
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.
    Bristow LJ; Bennett GW
    Br J Pharmacol; 1989 Jul; 97(3):745-52. PubMed ID: 2503226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels.
    Petersson M; Uvnäs-Moberg K
    Physiol Behav; 2004 Dec; 83(3):475-81. PubMed ID: 15581670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.
    Mishra RK; Chiu S; Chiu P; Mishra CP
    Methods Find Exp Clin Pharmacol; 1983; 5(4):203-33. PubMed ID: 6136640
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-endorphin suppresses release of thyrotropin-releasing hormone in rat hypothalamus during acute hypoxia exposure.
    Hou TD; Du JZ
    Acta Pharmacol Sin; 2002 Oct; 23(10):878-81. PubMed ID: 12370091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF, TRH, and simian social and motor behavior.
    Crowley TJ; Hydinger M
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):79-87. PubMed ID: 13417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.
    Crowley TJ; Hydinger M
    Psychopharmacology (Berl); 1977 Jul; 53(2):205-6. PubMed ID: 19803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.